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Abstract
Aims/hypothesis Endothelial cells (ECs) play an essential role
in pancreatic organogenesis. We hypothesise that effective
in vitro interactions between humanmicrovascular endothelial
cells (HMECs) and human pluripotent stem cells (hPSCs)
results in the generation of functional pancreatic beta cells.
Methods Embryoid bodies (EBs) derived from hPSCs
were cultured alone (controls) or with ECs in collagen
gels. Subsequently, cells were analysed for pancreatic beta
cell markers, and then isolated and expanded. Insulin
secretion in response to glucose was evaluated in vitro
by static and dynamic (perifusion) assays, and in vivo by
EB transplantation into immunodeficient mice.
Results Co-cultured EBs had a higher expression of mature
beta cells markers and enhanced insulin secretion in vitro,
compared with controls. In mice, transplanted EBs had higher
levels of human C-peptide secretion with a significant
reduction in hyperglycaemia after the selective destruction of
native pancreatic beta cells. In addition, there was significant
in vitro upregulation of bone morphogenetic proteins 2 and 4
(BMP-2, 4) in co-cultured cells, compared with controls.
Conclusions/interpretation ECs provide essential signalling
in vitro, such as activation of the BMP pathway, for derivation
of functional insulin-producing beta cells from hPSCs.
Keywords Endothelium . Insulin secretion in vitro . Stem
cells
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HMEC Human microvascular endothelial cell
hPSC Human pluripotent stem cell
IHC Immunohistochemical
iPSC Induced pluripotent stem cell
PDX1 Pancreatic and duodenal homeobox 1
SCID Severe combined immunodeficiency




The worldwide number of patients with diabetes is
projected to increase to 440 million by 2030 [1]. One
promising approach for the treatment of this disease is
transplantation of insulin-producing cells derived from
human pluripotent stem cells (hPSCs) [2–4]. Novel
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protocols have been described to derive functional beta
cells in culture [5]. However, these protocols are complex
and do not enable the expansion of pure beta cells. Most
reports describe the derivation of mouse, monkey and
human beta cells from stem cells, but only immature cells
are produced and in low numbers [6–8]. In vitro hPSCs
generate endocrine pancreatic precursors more readily than
mature beta cells [6, 9]. Mature beta cells have been
identified in vivo several weeks after murine transplanta-
tion of pancreatic progenitors that express pancreatic and
duodenal homeobox 1 (PDX1) or homeobox protein Nkx-
6.1 (NKX6.1) [9, 10]. hPSC-derived insulin-producing
cells do not express the mature beta cell marker,
urocortin-3 (UCN3), and have a low glucose threshold
for insulin release [11, 12]. However, they acquire a higher,
more physiological threshold and amplified insulin release
upon glucose challenge after transplantation [12]. These
facts strongly suggest that complex signals (the nature of
which are currently unknown) may be essential to generate
fully differentiated beta cells in vivo.
Endothelial cells (ECs) are major components of the
pancreatic niche [13, 14]. ECs play a key role in
organogenesis [8, 13, 15–18]; after induction from the
notochord, pancreatic bud cells interact with ECs from the
aorta and the dorsal vein to induce the formation of pancreas
progenitors [13, 14, 19]. Aortic ECs are crucial for the survival
of the pancreatic mesenchyme, including Islet-1+ cells, which
signal to induce the expression of PDX1, a master regulator of
pancreatic organogenesis [20]. The islet itself is one of the
most highly vascularised structures in the body and
components from the vascular basement membrane, as well
as EC-derived factors, are essential for insulin gene expression
in vitro and in vivo [19, 21–26]. Furthermore, the increase in
islet microvasculature density coincides with the growth of
islet endocrine cells observed after birth, suggesting a pivotal
role for ECs in postnatal endocrine cell maturation [27].
Signals from ECs promote upregulat ion of bone
morphogenetic protein 2 (BMP-2) and BMP-4 in mouse
models, leading to the differentiation of several organs
including the pancreas [8, 26]. Receptor activation of BMPs
promotes mothers against decapentaplegic homologue
(SMAD)-1, 5 and 8 phosphorylation and translocation to the
nucleus, where they function as transcription factors [28].
Importantly, BMP-4 variants have been associated with a
modest risk of type 2 diabetes mellitus, suggesting that
BMPs may be fundamental to the integrity of beta cell
function [29, 30]. In the present work, we used embryoid
bodies (EBs), derived from reprogrammed or embryonic
hPSCs, to investigate whether ECs enhance the in vitro
generation of functional insulin-producing cells cultured in
collagen–laminin scaffolds [21, 22, 31–33]. After labelling,
isolating, expanding and characterising these cells, we tested
their ability to release insulin in vitro, and also in vivo after
transplantation under the kidney capsule of streptozotocin
(STZ)-treated severe combined immunodeficient (SCID)
mice [34, 35]. Additionally, we found consistent upregulation
of BMP 2 and BMP4 only in EBs co-cultured with ECs,
suggesting an important role for these peptides in the
differentiation process.
Methods
Cells and reagents The hPSC cell line, 83iCTR-n1, and the
human embryonic stem cell line, H9 were obtained from the
induced pluripotent stem cell (iPSC) core laboratory,
Cedars-Sinai Regenerative Medicine Institute. These cells
were negative for mycoplasma in the same facility before
being used for differentiation experiments. At the core
laboratory, hPSC derivation from human fibroblasts was
performed according to published protocols [31, 32]. The
hPSC line was used at passage 40–50; H9 cells were used at
passage 20–30. Both cell lines were cultured in a feeder-free
system with mTeSR1 basal medium plus 5× supplement
(Invitrogen, Carlsbad, CA, USA), 200 μmol/l L-alanyl-
L-glutamine (American Type Culture Collection [ATCC],
Manassas, VA, USA) and 0.1 mmol/l β-mercaptoethanol
(STEMCELL Technologies, Vancouver, BC, Canada). EBs
were generated according to the manufacturer’s instructions
and maintained in AggreWell medium (STEMCELL
Technologies) supplemented with 10 μmol/l rho-associated
protein kinase (ROCK) inhibitor (Sigma-Aldrich, St Louis,
MO, USA). The human microvascular EC (HMEC) line was
purchased from E. Ades and F. J. Candal (Centers for Disease
Control and Prevention, Atlanta, GA, USA), and T. Lawley
(Emory University, Atlanta, GA, USA). HMECs were
negative for mycoplasma and were grown at 37°C under 5Q
CO2 and maintained in MCDB131 medium (Invitrogen)
supplemented with 1Q L-alanyl-glutamine (vol./vol.)
(ATCC), 10Q FBS (vol./vol.) (Omega Scientific, Tarzana,
CA, USA) and 100 μg/ml endothelial cell growth supplement
(Millipore, Hayward, CA, USA), for use at passages 20–25.
For co-culture experiments, 100 EBs were picked up with a
glass Pasteur pipette and 5×105 HMECs inactivated with
100 μl/ml mitomicyn C (Sigma-Aldrich) were added to
collagen I solution (BD Bioscience, Franklin Lakes, NJ,
USA) with 1× minimum essential media (MEM), 1 mol/l
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES) buffer, 7.5Q bicarbonate solution (vol./vol.) (Life
Technologies, Grand Island, NY, USA), 0.1 mmol/l NaOH,
1 mg/ml laminin I and 1 mg/ml collagen IV (R&D Systems,
Minneapolis, MN, USA) and placed on ice. Then, 10×100 μl
drops of cell suspension were placed into Petri dishes
(60× 20 mm; VWR, Cerritos, CA, USA) and solidified at
37°C for 10–20 min, after which, medium containing
pancreatic differentiation factors including activin A, Wnt3a,
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retinoic acid (RA), fibroblast growth factor 7 (FGF7),
epidermal growth factor (EGF), SB461542, hepatocyte
growth factor (HGF), insulin-like growth factor-1 (IGF-1),
and nicotinamide was added at different time points of EB
development [7]. EB controls were cultured in gel without
ECs but treated with the same pancreatic differentiation
factors. After 20 days, cells were harvested using 5Q
collagenase I (wt/vol.) (Worthington, Lakewood, NJ, USA)
and maintained in CMRL 1066 medium with CIT
modif icat ion (Mediatech, Manassas , VA, USA),
supplemented with 10 ml of 25Q human serum albumin
(HSA; NOVA Biologics, Oceanside, CA, USA) to a final
concentration of 0.5Q (vol./vol.), and 50μl of a 1 mg/ml stock
of IGF-1 (R&D Systems) at a final concentration of 10 ng/ml
(vol./vol.). To generate definitive endoderm (DE) cells, undif-
ferentiated iPSCs were cultured in a feeder-free system and
culture medium, as described above. Subsequently, cells were
transferred into six wells of a 24-well plate. At 90Q
confluency, RPMI 1640 (Life Technologies) containing
100 ng/ml activin A (Peprotech, Rocky Hill, NJ, USA) and
25 ng/ml Wnt3a (R&D Systems) was added to DE cells for
the first day. On the second and third days, the cell medium
was changed to RPMI 1640 containing only 100 ng/ml activin
A. The DE cells were plated in collagen gel (as described
above) with or without ECs, and pancreas differentiation
factors were added [7]. The human hepatoma cell line and
beta-TC-6 cells (ATCC) were both negative for mycoplasma.
Immunocytochemistry Cells were fixed with 4Q
paraformaldehyde (vol./vol.) (Polysciences, Warrington, PA,
USA), permeabilised with 0.3Q Triton X-100 (vol./vol.) in
PBS and then incubated with primary antibodies, as outlined
in the electronic supplementary material (ESM Table 1). The
antibodies were validated by the providers and in our
laboratory by staining frozen sections of human or mouse
pancreases (positive controls) and hepatoma cell lines
(negative controls) (data not shown). Images were acquired
using a multipurpose zoom microscope (Nikon AZ 100;
Nikon Instruments, Melville, NY, USA) attached to a
DS-Qi1 high-sensitivity charge-coupled device (CCD)
camera and analysed using NIS-Elements AR 3.10 (Nikon
Instruments) and ImageJ 1.30v (National Institutes of
Health, Bethesda, MD, USA) imaging software.
FACS
Differentiated cells were harvested and stained with primary,
secondary or isotype control antibodies (ESM Table 2). Cells
were then analysed in a BD LSRFortessa cell analyser (BD
Biosciences, San Jose, CA, USA) using fluorescence
excitation at 360 nm and emission at 565 nm.
Quantitative real-time reverse transcription-PCR analysis
Total RNAwas isolated from cells using an RNeasy mini kit
(Qiagen, Valencia, CA, USA). The QuantiTect reverse
transcription kit (Qiagen) was used to synthesise cDNA and
quantitative real-time reverse transcription PCR (qRT-PCR)
analysis was performed using a SYBR Green RT-PCR kit
(Qiagen) and a LightCycler instrument (Applied Biosystems,
Foster City, CA, USA). PCR cycle conditions are shown in
ESM Table 3. Analysis was performed using 7300 Sequence
Detection Software (SDS) version 1.3 (Software Core
Application, Applied Biosystems). Primer details are shown
in ESM Table 4.
Lentiviral plasmid construction and infection A lentiviral
reporter plasmid obtained from a viral core laboratory at
Cedars-Sinai Regenerative Medicine Institute was
constructed, containing a rat insulin minimal promoter that
was amplified via PCR using the forward primer,
5′-CCCTCTAGACCGGCTGAGCTAAGAATCCAG-3′ (the
XbaI sequence is underlined) and the reverse primer,
5 ′-GGCGACCGGTGCGGGAGTTACTGGGTCTCC
ACTAG-3′ (the AgeI sequence is underlined). After XbaI and
AgeI restriction enzyme digestion, the PCR product was
cloned into XbaI–AgeI sites upstream of themCherry reporter
gene in a self-inactivating second generation lentiviral vector
containing a constitutively expressed hrGFP-NLS reporter
under the control of the human ubiquitin C promoter.
Following the differentiation protocol, 5 × 104 insulin-
producing cells/ml at passage 0 were plated into gelatin
pre-coated 48-well plates. At 60Q confluence, cells were
transduced with the rat INS-mCherry lentiviral vector.
Transduction efficiency was quantified as the number of cells
expressing the hrGFP-NLS reporter.
hPSC-derived beta-like cell isolation and expansion After
cell expansion, 1 × 106 labelled cells at passage 1–2 were
harvested to obtain a cell suspension for sorting using a BD
FACSAria III cell sorter (BD Biosciences) with fluorescence
excitation at 360 nm and emission at 565 nm to detect
mCherry (red fluorescence signal) and green fluorescent
protein (GFP; green fluorescence signal) expression. After
sorting, cells were plated and passaged 3–7 times in CMRL
1066 media with CIT modification (Mediatech),
supplemented with 10 ml of 25Q HSA (wt/vol.) (NOVA
Biologics) and 50 μl of 1 mg/ml IGF-1 (R&D Systems) for
maintenance.
Quinacrine secretion assay Insulin-producing cells were
plated onto 24-well plates at 1×105 cells/ml and cultured at
37°C, 5Q CO2 for 24 h. The complete medium was then
replaced with medium containing 100 nmol/l quinacrine
dihydrochloride (Sigma-Aldrich, St. Louis, MO, USA) and
cells were incubated at 37°C, 5Q CO2 for 30 min. Images
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were obtained by fluorescence microscopy at 360 nm
excitation and 500 nm emission (Nikon AZ 100; Nikon
Instruments). After washing with PBS, cells were incubated
in RPMI 1640 supplemented with 0.1Q BSA (wt/vol.) and
different concentrations of glucose (0.5 mmol/l, 1.0 mmol/l,
2.8 mmol/l, 5.6 mmol/l or 16.5 mmol/l). Cell images were
taken after 1 h with a DS-Qi1 high-sensitivity charge-
coupled device (CCD) camera and analysed using ImageJ
1.30v (National Institutes of Health, MD, USA) software.
Human insulin andC-peptidemeasurementHuman insulin
and C-peptide were measured by ultrasensitive ELISA
(Mercodia, Winston-Salem, NC, USA). The detection limits
were 0.42 pmol/l for insulin and <2.5 pmol/l for C-peptide.
Perifusion assay Perifusion assays were performed using
beta-TC-6 (positive control) or insulin-producing cells
derived from co-cultures or controls [36]. Cells were perifused
at 100 μl/min with Krebs-Ringer bicarbonate buffer (KRBH)
containing 3 mmol/l glucose. After a 60 min equilibrium
period (−60 to 0 min), cells were stimulated with 15 mmol/l
glucose for 40 min, after which the perifusion solution was
switched to 3 mmol/l glucose. Samples were collected every
minute from −5 to 10 min; thereafter, samples were collected
every 2 min from 12 to 26 min. Beta cell function was
expressed as pmol/l insulin and as the percentage increase in
insulin release relative to baseline.
Cell transplantation in SCID mice Animal experiments
were approved by the Cedars-Sinai Animal Care and Use
Committee. Thirty male SCID mice of the C.B-17/IcrHsd-
PrkdcscidLystbg-J strain (Envigo, Indianapolis, IN, USA)
were divided into three groups of ten mice. Animal care
was undertaken by the Comparative Medicine department
in agreement with the committee. The cages were housed
in random order and physical randomisation was
performed to assign mouse treatment (e.g. a piece of paper
labelled with the animal ID number was withdrawn from a
receptacle that was shaken and a treatment was assigned to
this animal). All outcome assessments were carried out in
random order by an investigator who was blind to the
treatment groups. In the first group, 3 × 106 insulin-
producing cells derived from EBs co-cultured with ECs
were transplanted under the kidney capsule. The second
group received insulin-producing cells derived from EBs
cultured alone. The third (control) group were injected
with an equivalent volume of PBS. After 90 days, all mice
underwent an IPGTTwith 30Q dextrose (wt/vol.) at 3 g/kg
body weight. Blood samples were taken before glucose
challenge and at 0, 30 and 60 min after injection. At
105 days after transplantation, mice were i.p. injected with
STZ (Sigma-Aldrich) for 5 consecutive days (total dose:
350 mg/kg). A second IPGTTwas performed 2 weeks after
STZ treatment. Mice were euthanised approximately
126 days after transplantation (21 days after STZ treat-
ment) and the left kidneys (harbouring the transplanted
cells) were removed for immunohistochemical (IHC)
analysis. The data from two animals from the control group
and one animal transplanted with cells derived from EBs
alone were excluded as the animals were euthanised due to
moribund aspect after STZ injections.
Immunohistochemistry
Insulin, glucagon and somatostatin levels were detected in
kidney sections using a Leica DM 750 HD Digital
Microscope (Leica Microsystems, Buffalo Grove, IL,
USA) and commercially available primary antibodies
(ESM Table 5) , after microwave heat-induced epitope
retrieval using an automated detection system: either a
Leica BOND-MAX (Leica Microsystems) or a Dako
autostainer (Dako, Carpinteria, CA, USA).
Statistical analysis Data are expressed as the mean±SE of
























Fig. 1 Co-expression of proinsulin plus PDX1 or proinsulin plus CD31
in EBs cultured alone or with ECs. EBs cultured (a–c) alone or (d–f) co-
cultured with ECs were (a, b, d, e) untreated or (c, f) treated with growth
factor (GF), then analysed by (a, d) bright-field light microscopy or co-
stained for proinsulin (green) and PDX1 (red). (g–i) EBs co-cultured with
ECs and treated with growth factors were co-stained with proinsulin
(green) and CD31 (red); (h) confocal image. (a, d) Scale bar, 100 μm;
(b, c, e, f, i) scale bar, 25 μm; (g) scale bar, 200 μm; (h) scale bar, 10 μm,
n= 3
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identify significant differences between test groups
(GraphPad Prism, La Jolla, CA, USA)
Results
ECs promote differentiation of hPSCs to insulin-
producing cells EBs cultured alone in collagen–laminin gels
and not treated with growth factors were used as controls and
compared with EBs co-cultured with ECs. EBs alone
expressed lower levels of proinsulin and PDX1 (Fig. 1a–c).
In contrast, co-cultured EBs (Fig. 1d) expressed a higher level
of proinsulin and PDX1 (Fig. 1e) that was enhanced by the
addition of growth factors (Fig. 1f). Tube-like structures were
observed to surround co-cultured EBs (Fig. 1d) and a rich
network of endogenous blood vessels expressing CD31
appeared contiguous with nascent insulin-producing cells
(Fig. 1g–i). After harvesting, cells derived from co-cultures
had increased expression of beta cell markers, such as
proinsulin (Fig. 2a), UCN3 (Fig. 2b), and Nkx6.1 (Fig. 2c),
compared with controls (Fig. 2d–f). Gene expression data
corroborated the immunocytochemical observations,
indicating a significantly higher level of beta cell marker
expression in sorted cells derived from co-cultures at passage
3 (Fig. 2g) than in cells not co-cultured. Sorted cells also had
significantly lower glucagon and somatostatin expression than
insulin expression (Fig. 2g). FACS analysis showed that about
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Fig. 2 Analysis of pancreatic beta cell markers in EBs cultured alone or
with ECs. (a–c) Co-cultured EBs or (d–f) EBs cultured alone were
stained for (a, d) proinsulin (red), (b, e) UCN3 (red) or (c, f) Nkx6.1
(red). (g) Absolute gene expression in human pancreatic tissue, ECs,
sorted cells derived from EBs cultured alone (iPSC-EBs), and sorted cells
derived from EBs co-cultured with ECs at passage 0 (iPSC-EBs+ECs



















Fig. 3 Isolation of insulin-
producing cells from EBs
cultured alone or with ECs. (a–d)
Sorted insulin-producing cells
derived from co-cultures were
analysed by (a) bright-field light
microscopy or labelled with (b)
mCherry (red) or (c) GFP (green);
(d) merged image. (e)
Proliferation of insulin-producing
cells. (f) Islet-like cluster
formation. (g) Insulin-producing
cells derived from EBs cultured
alone and (h) mCherry and GFP
expression in these cells. (i–l)
Human hepatoma cells analysed
by (i) bright-field light
microscopy or labelled with (j)
mCherry or (k) GFP; (l) merged
image. (m–p) Beta-TC-6
analysed by (m) bright-field light
microscopy or labelled with (n)
mCherry or (o) GFP; (p) merged
image. (a–e, g, h) Scale bar, 25
μm; (f, i–p) scale bar, 100 μm,
n= 3
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contrast to about 10Q of growth factor-treated controls (ESM
Fig.1a–f).
Insulin-producing cells derived from EB–EC co-cultures
can be labelled, isolated and expanded in vitro Labelled
insulin-producing cells from co-cultured EBs expressed
mCherry (Fig. 3a–d). These cells proliferated in vitro and
formed islet-like clusters (Fig. 3e, f). Although they
proliferated slowly, islet-like cluster formation became more
frequent at later passages in cells plated in collagen-laminin
gels (e.g. passage 3, as shown in ESM Fig 1g–j). In contrast,
we observed very few viable cells expressing mCherry from
EBs treated with growth factor in the absence of ECs
(Fig. 3g, h). The human hepatoma cell line and beta-TC-6
cells were used as negative (Fig. 3i–l) or positive control
(Fig. 3m–p) respectively.
Insulin-producing cells derived from co-cultures respond
efficiently to in vitro glucose challenge Quinacrine
accumulates within insulin granules after 30 min; maximum
fluorescence was detected in sorted cells derived from
co-cultures (Fig. 4a), in contrast to low/no fluorescence in
controls (Fig. 4a, inset). A significant decrease in fluorescence
was observed after adding 1.0 mmol/l glucose and then
increasing the concentration to 16.5 mmol/l (Fig. 4b, c). A
threefold increase in human C-peptide levels was found in
the medium from insulin-producing cells derived from
co-cultures following challenge with 3 to 17 mmol/l glucose
(Fig. 4d). In contrast, no C-peptide production was seen in
EBs cultured alone (Fig. 4d). The kinetics of insulin secretion
was quantified using a perifusion assay. Beta-TC-6 cells had
an initial fast response followed by a slow response and
oscillations (Fig. 4e). Human induced PSCs (hiPSCs) at
passage 1 responded to glucose with an increasing amplitude
in insulin oscillations that occurred with a frequency of about
one oscillation every 12–14 min (Fig. 4f). At passage 3, the
same cells showed more frequent oscillations with lower
insulin peaks (Fig. 4g). Similarly, insulin-producing cells
derived from the H9 human embryonic stem cell line
exhibited a clear oscillatory response to glucose challenge,
with higher insulin levels with more frequent oscillations at
passage 7 (Fig. 4h) and lower insulin levels with less frequent
oscillations at passage 15 (Fig. 4i).
Pancreatic beta cells derived from EB–EC co-cultures
respond to glucose challenge in vivo Sorted hPSC-derived
insulin-producing cells, capable of responding to glucose
in vitro, were expanded in culture. About 5 × 106 cells at
passage 3–4 were transplanted under the kidney capsule of
SCID mice. Ninety days after transplantation, an IPGTT was
performed. Following glucose challenge, the blood glucose
level in control mice grafted with cells derived from EBs
cultured alone ranged from 8 to 21 mmol/l with negligible
human C-peptide detected (Fig. 5a, b). Concurrently, mice
grafted with cells derived from co-cultures demonstrated
nearly identical blood glucose levels but human C-peptide
levels rose from 43 pmol/l at baseline to 100 pmol/l at
30 min and 69 pmol/l at 60 min (Fig. 5a, b). Mice were then
treated with STZ to destroy native beta cells and glucose
levels were measured 15 days later (Fig. 5c). Blood glucose
levels were significantly lower in mice transplanted with
co-cultured EBs (16.3±6.1 mmol/l) compared with controls
(30.3±2.5 mmol/l, p=0.0165) when assessed 2 weeks after
STZ treatment. IHC analysis showed plentiful insulin-
expressing cells in the kidney capsule of mice grafted with
cells derived from co-cultures (Fig. 5d, black arrows); in
























































































































Fig. 4 Quinacrine, human C-peptide and insulin secretion in insulin-
producing cells derived from EBs cultured alone or with ECs. (a–c)
Quinacrine was loaded for 30 min onto static cultures of co-cultured cells
or (a) controls (inset), followed by the addition of (b) 1 mmol/l or (c)
16.5 mmol/l glucose. (d) Quantification of human C-peptide secretion in
static cultures after 3 mmol/l (black bars) or 17 mmol/l (grey bars) glu-
cose. (e–i) Dynamic insulin secretion (perifusion) was measured during
40 min after changing the glucose concentration from 3 to 15 mmol/l at
time 0 and from 15 to 3 mmol/l at 40 min, in (e) beta-TC-6 cells, (f)
hPSC-insulin-producing cells at passage 1, (g) hPSC-insulin-producing
cells at passage 3, (h) H9-insulin-producing cells at passage 7 and (i) H9-
insulin-producing cells at passage 15. (a–c) Scale bar, 25 μm; (a) inset
scale bar, 25 μm *p< 0.05, n = 3
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contrast, there was no evidence of insulin expression in
control mice (Fig. 5e).
Discussion
During fetal development, a pancreatic beta cell mass results
from islet neogenesis [36]. However, the factors involved in
beta cell maturation in vivo are not completely understood.
ECs are key components of the pancreatic niche and their
absence can result in pancreatic agenesis [17, 21, 37]. In the
present study, we used EBs and ECs to derive functional
insulin-producing cells in vitro. We focused on promoting
cell–cell interactions in vitro between ECs and human EBs,
which are structures composed of cells derived from all three
germ layers [38]. Our results indicate that insulin-producing
cells are generated in vitro in EBs surrounded by ECs. These
insulin-producing cells responded to glucose both in vitro and
in vivo. Within the EBs, some ECs were located close to
insulin-producing cells, suggesting that paracrine effects
may also be essential to maintain the beta cell phenotype
[8]. This hypothesis is supported by previous observations in
mouse embryonic stem cells, where ECs promote beta cell
maturation [8]. Beta cells also secrete soluble factors that
affect the EC phenotype [39]. Islet ECs correspond to
fenestrated endothelium [40]. Interestingly, beta cells exhibit
polarity, with an apical and basolateral membrane and a
greater density of insulin vesicles in the apical region close
to ECs [14, 19]. These facts suggest that signals from beta
cells and ECs are essential for beta cell function. For instance,
insulin promotes an increase in nitric oxide synthase and
vascular endothelial growth factor (VEGF)-A induces cell
proliferation and maintains fenestrations in ECs [40]. In our
experiments, these cell–cell interactions led to a higher yield
and improved survival of insulin-producing cells and
improved cellular function. We isolated, expanded and
labelled these insulin-producing cells and found that the
expression of mCherry (driven by the insulin promoter)
decreased as the expression of GFP (driven by the ubiquitin
C promoter) increased, suggesting that ubiquitination may
interfere with insulin promoter activation, and thus limit the
number of isolated insulin-producing cells [41–43]. Insulin-
producing cells expressed markers of mature beta cells
(UCN3, proinsulin, INS, PDX1, NKX6-1, KCNJ11, ABCC8,
GCK, PCSK1, PKD2 and SLC2A1). Some sorted cells also
expressed islet cell markers (GCG, SST), suggesting that,
following differentiation, the cell population included
pancreas progenitors. In agreement with previous
observations, insulin-producing cells from co-cultures
proliferated in vitro [44]. However, decreased insulin
expression resembling levels in islet cells was observed after
in vitro expansion [45, 46]. Insulin-producing cells derived
from co-cultures retained secretory ability, as assessed by
quinacrine assay [47]. Perfusion assays and a threefold
increase in C-peptide secretion after a glucose challenge in
static cultures corroborated the beta cell phenotype in vitro.
Additionally, we found oscillations in insulin secretion at
higher glucose concentrations. This oscillatory secretion is
essential for maintaining glucose homeostasis and a suitable
insulin response in target cells [48]. Previous studies have also












































































Fig. 5 IPGTTand STZ treatment in mice grafted with insulin-producing
cells derived from EBs cultured alone or co-cultured with ECs. (a) Blood
glucose levels and (b) human C-peptide blood levels in mice transplanted
with cells from EBs cultured alone (black squares) or EBs co-cultured
with ECs (white squares). (c) Blood glucose levels in grafted mice before
and after treatment with STZ. (d) Mouse kidney (K) and kidney capsule
(KC) with grafted insulin-producing cells derived from EBs co-cultured
with ECs that express insulin (arrows, insulin-positive cell clusters
[stained black]). Inset shows the cells at higher magnification. (e)
Images from control mice grafted with EBs cultured alone. Inset shows
a normal human pancreas (P) with islets stained in black. Scale bars,
200 μm; (d) inset scale bar, 50 μm; (e) inset scale bar, 25 μm.
*p< 0.05, n = 3
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demonstrated an insulin secretion pattern in human beta cells
derived from human embryonic stem cells [49]. Higher levels
of C-peptide in vivo after glucose challenge and control of
hyperglycaemia in STZ-treated mice strongly suggest that
insulin-producing cells derived from the interactions between
EBs and ECs maintain their functional capacity after
transplantation in SCID mice. This finding could be relevant
for the use of these cells as an alternative treatment for type 1
diabetes mellitus. In co-cultured EBs, we observed cell
clusters that co-expressed p-SMAD1, 5 and 8, and a
significant increase in BMP expression (ESM Fig. 2).
Analysis of EC-conditioned medium showed that a higher
level of BMP-2 and BMP4 expression was induced at stage
three of differentiation in co-cultured EBs (ESM Fig. 3).
Furthermore, the use of EC-conditioned medium improved
the proliferation and survival of insulin-producing cells at
various stages of differentiation (ESM Fig. 3). In contrast, less
proliferation and more cell death was observed in EBs
cultured alone. Thus, EC-derived factors in concert with
pancreatic differentiation factors may potentiate cell survival,
differentiation, proliferation and maturation in vitro. Finally,
the effects of ECs were mimicked by adding a combination of
BMP-2 and BMP-4 to DE cells that expressed CXCR4 and
became insulin-producing cells (ESM Fig. 4).
In this study, we demonstrate that human dermal ECs
provide essential signals for in vitro derivation of
functional insulin-producing cells from hPSCs. These
insulin-producing cells can be labelled, isolated and
expanded, and maintain insulin secretion in vitro and
in vivo. Optimised EB–EC interactions promote
upregulation of BMPs that may be essential for the beta
cell differentiation process. Long-term studies in animal
models of diabetes are required to evaluate the capacity
of these insulin-producing cells to maintain glucose
homeostasis, for use in the treatment of type 1 diabetes
mellitus.
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